000284950 001__ 284950
000284950 005__ 20240229155058.0
000284950 0247_ $$2doi$$a10.1097/RLI.0000000000000981
000284950 0247_ $$2pmid$$apmid:37185832
000284950 0247_ $$2ISSN$$a0020-9996
000284950 0247_ $$2ISSN$$a1536-0210
000284950 0247_ $$2altmetric$$aaltmetric:148425518
000284950 037__ $$aDKFZ-2023-02148
000284950 041__ $$aEnglish
000284950 082__ $$a610
000284950 1001_ $$aWilferth, Tobias$$b0
000284950 245__ $$aInfluence of Residual Quadrupolar Interaction on Quantitative Sodium Brain Magnetic Resonance Imaging of Patients With Multiple Sclerosis.
000284950 260__ $$a[Erscheinungsort nicht ermittelbar]$$bOvid$$c2023
000284950 3367_ $$2DRIVER$$aarticle
000284950 3367_ $$2DataCite$$aOutput Types/Journal article
000284950 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1698413735_6651
000284950 3367_ $$2BibTeX$$aARTICLE
000284950 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000284950 3367_ $$00$$2EndNote$$aJournal Article
000284950 500__ $$a#LA:E020#
000284950 520__ $$aThe purpose of this work was to evaluate the influence of residual quadrupolar interaction on the determination of human brain apparent tissue sodium concentrations (aTSCs) using quantitative sodium magnetic resonance imaging ( 23 Na MRI) in healthy controls (HCs) and patients with multiple sclerosis (MS). Especially, it was investigated if the more detailed examination of residual quadrupolar interaction effects enables further analysis of the observed 23 Na MRI signal increase in MS patients.23 Na MRI with a 7 T MR system was performed on 21 HC and 50 MS patients covering all MS subtypes (25 patients with relapsing-remitting MS, 14 patients with secondary progressive MS, and 11 patients with primary progressive MS) using 2 different 23 Na pulse sequences for quantification: a commonly used standard sequence (aTSC Std ) as well as a sequence with shorter excitation pulse length and lower flip angle for minimizing signal loss resulting from residual quadrupolar interactions (aTSC SP ). Apparent tissue sodium concentration was determined using the same postprocessing pipeline including correction of the receive profile of the radiofrequency coil, partial volume correction, and relaxation correction. Spin dynamic simulations of spin-3/2 nuclei were performed to aid in the understanding of the measurement results and to get deeper insight in the underlying mechanisms.In normal-appearing white matter (NAWM) of HC and all MS subtypes, the aTSC SP values were approximately 20% higher than the aTSC Std values ( P < 0.001). In addition, the ratio aTSC SP /aTSC Std was significantly higher in NAWM than in normal-appearing gray matter (NAGM) for all subject cohorts ( P < 0.002). In NAWM, aTSC Std values were significantly higher in primary progressive MS compared with HC ( P = 0.01) as well as relapsing-remitting MS ( P = 0.03). However, in contrast, no significant differences between the subject cohorts were found for aTSC SP . Spin simulations assuming the occurrence of residual quadrupolar interaction in NAWM were in good accordance with the measurement results, in particular, the ratio aTSC SP /aTSC Std in NAWM and NAGM.Our results showed that residual quadrupolar interactions in white matter regions of the human brain have an influence on aTSC quantification and therefore must be considered, especially in pathologies with expected microstructural changes such as loss of myelin in MS. Furthermore, the more detailed examination of residual quadrupolar interactions may lead to a better understanding of the pathologies themselves.
000284950 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000284950 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000284950 650_7 $$09NEZ333N27$$2NLM Chemicals$$aSodium
000284950 650_2 $$2MeSH$$aHumans
000284950 650_2 $$2MeSH$$aMultiple Sclerosis: diagnostic imaging
000284950 650_2 $$2MeSH$$aMultiple Sclerosis: pathology
000284950 650_2 $$2MeSH$$aSodium
000284950 650_2 $$2MeSH$$aBrain: diagnostic imaging
000284950 650_2 $$2MeSH$$aBrain: pathology
000284950 650_2 $$2MeSH$$aMagnetic Resonance Imaging: methods
000284950 650_2 $$2MeSH$$aMultiple Sclerosis, Relapsing-Remitting: diagnostic imaging
000284950 650_2 $$2MeSH$$aMultiple Sclerosis, Relapsing-Remitting: pathology
000284950 650_2 $$2MeSH$$aSexually Transmitted Diseases: pathology
000284950 7001_ $$aMennecke, Angelika$$b1
000284950 7001_ $$aHuhn, Konstantin$$b2
000284950 7001_ $$aUder, Michael$$b3
000284950 7001_ $$aDoerfler, Arnd$$b4
000284950 7001_ $$aSchmidt, Manuel$$b5
000284950 7001_ $$0P:(DE-He78)054fd7a5195b75b11fbdc5c360276011$$aNagel, Armin$$b6$$eLast author$$udkfz
000284950 773__ $$0PERI:(DE-600)2041543-6$$a10.1097/RLI.0000000000000981$$gVol. 58, no. 10, p. 730 - 739$$n10$$p730 - 739$$tInvestigative radiology$$v58$$x0020-9996$$y2023
000284950 909CO $$ooai:inrepo02.dkfz.de:284950$$pVDB
000284950 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)054fd7a5195b75b11fbdc5c360276011$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000284950 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000284950 9141_ $$y2023
000284950 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-09-02
000284950 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-09-02
000284950 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-09-02
000284950 915__ $$0StatID:(DE-HGF)0410$$2StatID$$aAllianz-Lizenz$$d2023-10-24$$wger
000284950 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-24
000284950 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-24
000284950 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-24
000284950 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-24
000284950 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-24
000284950 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-24
000284950 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINVEST RADIOL : 2022$$d2023-10-24
000284950 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-24
000284950 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bINVEST RADIOL : 2022$$d2023-10-24
000284950 9202_ $$0I:(DE-He78)E020-20160331$$kE020$$lE020 Med. Physik in der Radiologie$$x0
000284950 9201_ $$0I:(DE-He78)E020-20160331$$kE020$$lE020 Med. Physik in der Radiologie$$x0
000284950 980__ $$ajournal
000284950 980__ $$aVDB
000284950 980__ $$aI:(DE-He78)E020-20160331
000284950 980__ $$aUNRESTRICTED